Longeveron IncNASDAQ:LGVN
- LAST PRICE1.6600
- TODAY'S CHANGE (%)-0.0600 (-3.4884%)
- Bid / Lots1.6700/ 3
- Ask / Lots1.7100/ 3
- Open / Previous Close1.7200 / 1.7200
- Day Range
- 52 Week Range
- Volume319,845
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LGVN |
|---|---|---|
| 09:32 ET | 9244 | 1.63 |
| 09:34 ET | 799 | 1.6807 |
| 09:36 ET | 9350 | 1.64 |
| 09:38 ET | 5641 | 1.6687 |
| 09:39 ET | 3199 | 1.62 |
| 09:41 ET | 7902 | 1.6206 |
| 09:43 ET | 7803 | 1.61 |
| 09:45 ET | 549 | 1.62 |
| 09:48 ET | 1000 | 1.65 |
| 09:50 ET | 2250 | 1.6555 |
| 09:52 ET | 17151 | 1.6199 |
| 09:54 ET | 686 | 1.6283 |
| 09:56 ET | 15565 | 1.6 |
| 09:57 ET | 5012 | 1.63 |
| 09:59 ET | 490 | 1.6276 |
| 10:03 ET | 1791 | 1.6294 |
| 10:06 ET | 195 | 1.63 |
| 10:08 ET | 100 | 1.6399 |
| 10:10 ET | 936 | 1.6394 |
| 10:12 ET | 100 | 1.64 |
| 10:14 ET | 272 | 1.6301 |
| 10:17 ET | 515 | 1.6201 |
| 10:19 ET | 423 | 1.64 |
| 10:24 ET | 650 | 1.6293 |
| 10:26 ET | 2500 | 1.63 |
| 10:28 ET | 1861 | 1.63 |
| 10:30 ET | 2314 | 1.6289 |
| 10:32 ET | 600 | 1.625 |
| 10:33 ET | 628 | 1.63 |
| 10:35 ET | 549 | 1.63 |
| 10:37 ET | 1332 | 1.63 |
| 10:44 ET | 1544 | 1.64 |
| 10:46 ET | 246 | 1.64 |
| 10:50 ET | 700 | 1.63 |
| 10:55 ET | 23458 | 1.6 |
| 11:00 ET | 635 | 1.6027 |
| 11:04 ET | 100 | 1.62 |
| 11:06 ET | 100 | 1.62 |
| 11:08 ET | 1166 | 1.62 |
| 11:09 ET | 400 | 1.63 |
| 11:11 ET | 700 | 1.64 |
| 11:13 ET | 100 | 1.63 |
| 11:15 ET | 500 | 1.63 |
| 11:18 ET | 190 | 1.621 |
| 11:20 ET | 100 | 1.64 |
| 11:22 ET | 9967 | 1.62 |
| 11:24 ET | 1017 | 1.6025 |
| 11:29 ET | 1520 | 1.61 |
| 11:31 ET | 300 | 1.63 |
| 11:38 ET | 304 | 1.62 |
| 11:40 ET | 1400 | 1.62 |
| 11:42 ET | 416 | 1.62 |
| 11:44 ET | 360 | 1.63 |
| 11:45 ET | 1100 | 1.63 |
| 11:47 ET | 758 | 1.64 |
| 11:49 ET | 100 | 1.6465 |
| 11:51 ET | 127 | 1.6478 |
| 11:54 ET | 500 | 1.63 |
| 12:00 ET | 998 | 1.638 |
| 12:02 ET | 8057 | 1.6 |
| 12:05 ET | 4100 | 1.61 |
| 12:07 ET | 100 | 1.62 |
| 12:09 ET | 200 | 1.6292 |
| 12:12 ET | 1999 | 1.6291 |
| 12:20 ET | 300 | 1.62 |
| 12:21 ET | 2158 | 1.61 |
| 12:25 ET | 3448 | 1.61 |
| 12:32 ET | 3920 | 1.62 |
| 12:36 ET | 2595 | 1.618 |
| 12:38 ET | 928 | 1.62 |
| 12:41 ET | 1954 | 1.61 |
| 12:45 ET | 125 | 1.6199 |
| 12:48 ET | 10447 | 1.6 |
| 12:52 ET | 2400 | 1.6098 |
| 12:54 ET | 1126 | 1.605 |
| 12:59 ET | 100 | 1.61 |
| 01:01 ET | 900 | 1.61 |
| 01:10 ET | 300 | 1.615 |
| 01:14 ET | 2162 | 1.63 |
| 01:15 ET | 200 | 1.615 |
| 01:17 ET | 3089 | 1.64 |
| 01:19 ET | 179 | 1.63 |
| 01:24 ET | 7748 | 1.61 |
| 01:35 ET | 900 | 1.62 |
| 01:39 ET | 1000 | 1.65 |
| 01:44 ET | 900 | 1.6206 |
| 01:46 ET | 9786 | 1.6499 |
| 01:50 ET | 400 | 1.65 |
| 01:51 ET | 100 | 1.65 |
| 02:00 ET | 101 | 1.6401 |
| 02:11 ET | 581 | 1.645 |
| 02:13 ET | 500 | 1.6499 |
| 02:29 ET | 202 | 1.64 |
| 02:33 ET | 1076 | 1.64 |
| 02:45 ET | 500 | 1.64 |
| 02:47 ET | 300 | 1.6302 |
| 02:51 ET | 5284 | 1.66 |
| 02:54 ET | 100 | 1.65 |
| 02:56 ET | 100 | 1.66 |
| 03:03 ET | 700 | 1.6687 |
| 03:05 ET | 301 | 1.6599 |
| 03:07 ET | 200 | 1.6617 |
| 03:09 ET | 900 | 1.66 |
| 03:20 ET | 9250 | 1.6517 |
| 03:21 ET | 724 | 1.67 |
| 03:23 ET | 454 | 1.67 |
| 03:27 ET | 4584 | 1.6713 |
| 03:30 ET | 100 | 1.675 |
| 03:32 ET | 500 | 1.675 |
| 03:34 ET | 995 | 1.68 |
| 03:39 ET | 3991 | 1.67 |
| 03:41 ET | 1972 | 1.6796 |
| 03:43 ET | 3178 | 1.6652 |
| 03:45 ET | 6585 | 1.65 |
| 03:48 ET | 1000 | 1.652 |
| 03:50 ET | 2926 | 1.6799 |
| 03:52 ET | 2595 | 1.66 |
| 03:54 ET | 5537 | 1.665 |
| 03:56 ET | 11747 | 1.64 |
| 03:59 ET | 1698 | 1.67 |
Today
Longeveron to Present at the Planet MicroCap Showcase, from 19 minutes ago by Dow Jones
19 minutes ago by Dow Jones
Apr 18, 2024
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering, from 4:05PM ET on Thursday Apr 18, 2024 by Dow Jones
4:05PM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 17, 2024
DJ Longeveron Shares Drop 31% After Exercise of Warrants, from 10:19AM ET on Wednesday Apr 17, 2024 by Dow Jones
10:19AM ET on Wednesday Apr 17, 2024 by Dow JonesLongeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds, from 8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 15, 2024
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B(TM) in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC), from 8:30AM ET on Monday Apr 15, 2024 by Dow Jones
8:30AM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Longeveron Inc | 8.3M | -0.2x | --- |
TFF Pharmaceuticals Inc | 7.6M | -0.2x | --- |
Vaccinex Inc | 7.9M | -0.1x | --- |
Azitra Inc | 6.5M | -0.1x | --- |
Theralink Technologies Inc | 6.2M | -0.5x | --- |
Notable Labs Ltd | 8.8M | -0.3x | --- |
Company Information
Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.
Contact Information
- Headquarters
- 1951 NW 7th Ave, Ste 520MIAMI, FL, United States 33136
- Phone
- 305-302-7158
- Fax
- 302-674-5266
Executives
- Chairman of the Board, Co-Founder, Chief Science Officer
- Joshua Hare
- Chief Executive Officer, Director
- Wa'el Hashad
- Co-Founder, Director
- Donald Soffer
- Chief Financial Officer, Executive Vice President
- Lisa Locklear
- General Counsel, Corporate Secretary, International Executive Director
- Paul Lehr
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.3M |
|---|---|
Revenue (TTM) | $709.0K |
Shares Outstanding | 4.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-10.18 |
Book Value | $0.42 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 11.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,008.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
